4 results match your criteria: "N. Musi: Audie L. Murphy VA Medical Center[Affiliation]"
BackgroundStudies in cell cultures and rodents suggest that TLR4 is involved in the pathogenesis of insulin resistance, but direct data in humans are limited. We tested the hypothesis that pharmacologic blockade of TLR4 with the competitive inhibitor eritoran would improve insulin resistance in humans.MethodsIn protocol I, 10 lean, healthy individuals received the following 72-hour i.
View Article and Find Full Text PDFJ Am Med Dir Assoc
September 2021
Sealy Center on Aging, University of Texas Medical Branch, Galveston, TX, USA.
Objectives: Obesity is associated with sarcopenia in older adults, and weight loss can lead to further muscle mass loss. Oxytocin decreases with age, and animal studies suggest that oxytocin administration has trophic effects on skeletal muscle cells and reduces adiposity. We conducted a clinical trial to examine the safety and preliminary efficacy of intranasal oxytocin for older adults with sarcopenic obesity.
View Article and Find Full Text PDFPLoS One
July 2018
Barshop Institute of Longevity and Aging Studies, UT Health San Antonio, San Antonio, Texas, United States of America.
Objective: The root cause behind the low-grade inflammatory state seen in insulin resistant (obesity and type 2 diabetes) states is unclear. Insulin resistant subjects have elevations in plasma free fatty acids (FFA), which are ligands for the pro-inflammatory toll-like receptor (TLR)4 pathway. We tested the hypothesis that an experimental elevation in plasma FFA (within physiological levels) in lean individuals would upregulate TLR4 and activate downstream pathways (e.
View Article and Find Full Text PDFJ Physiol
June 2013
N. Musi: Audie L. Murphy VA Medical Center, 7400 Merton Minter, San Antonio, TX 78229, USA.
Free fatty acids (FFAs) have been implicated in the pathogenesis of insulin resistance. Reducing plasma FFA concentration in obese and type 2 diabetic (T2DM) subjects improves insulin sensitivity. However, the molecular mechanism by which FFA reduction improves insulin sensitivity in human subjects is not fully understood.
View Article and Find Full Text PDF